Enoxaparin sodium
average Mw：3800~5000
- Product Code: 183468
Alias:
Heparin sodium; adiparin sodium; heparin sodium salt; coagulation antigen; paparin sodium; hephospholipid sodium salt; daheparin sodium, related CAS number: 9041-08-1; NONE7026
CAS:
679809-58-6
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00081689 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2~8°C |
Product Description:
Used as an anticoagulant to prevent and treat blood clots in conditions such as deep vein thrombosis and pulmonary embolism. Commonly administered during hemodialysis and after surgeries, especially orthopedic procedures like hip or knee replacement. Also used in acute coronary syndrome to reduce the risk of heart attacks. Its predictable pharmacokinetics allows for subcutaneous dosing without frequent blood monitoring, making it suitable for outpatient treatment.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White or almost white powder |
| Average MW | 3800-5000 |
| Percentage of Mass Weight (<2000) | 12.0%-20.0% |
| Infrared Spectrum | Conforms to Structure |
| Percentage of mass weight (2000-8000) | 68.0-82.0% |
| SO4^2- / COO- | ≥1.8 |
| Nitrogen | 1.5-2.5% |
| Loss on Drying | <=10.0% |
| Sodium | 11.3%-13.5% |
| Bacterial Endotoxin | <0.01EU/Anti-FXa IU of LMMH |
| Benzyl alcohol | <=0.1% |
| specific absorbance (213 nm, dried substance) | 14.0-20.0 |
| Microbiological examination (TAMC) | <=10 CFU/g |
| Microbiological examination (TYMC) | <=10 CFU/g |
| Solvents (Ethanol) | <=5000ppm |
| Solvents (DMF) | <= 880 ppm |
| Anti-factor Xa activity (dried substance) | 90.0-125.0 IU/mg |
| Anti-factor IIa activity (dried substance) | 20.0-35.0 IU/mg |
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 200mg | 10-20 days | ฿3,260.00 |
+
-
|
| 1g | 10-20 days | ฿11,060.00 |
+
-
|
| 5g | 10-20 days | ฿32,200.00 |
+
-
|
Enoxaparin sodium
Used as an anticoagulant to prevent and treat blood clots in conditions such as deep vein thrombosis and pulmonary embolism. Commonly administered during hemodialysis and after surgeries, especially orthopedic procedures like hip or knee replacement. Also used in acute coronary syndrome to reduce the risk of heart attacks. Its predictable pharmacokinetics allows for subcutaneous dosing without frequent blood monitoring, making it suitable for outpatient treatment.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :